Itepekimab (SAR440340)
ACT18421
Phase 2 small_molecule active
Quick answer
Itepekimab (SAR440340) for Chronic Rhinosinusitis Without Nasal Polyps is a Phase 2 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Chronic Rhinosinusitis Without Nasal Polyps
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active